Gori S, Frayle H, Pagan A, Soldà M, Romagnolo C, Insacco E, Laurino L, Matteucci M, Sordi G, Busato E, Zorzi M, Maggino T, Del Mistro A; CIN2 study...
Cervical cancer screening
Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus
Martello G, Gori S, Frayle H, Franceschi S, Zorzi M, Del Mistro A. Prev Med Rep. 2023 Sep 22;36:102438. doi: 10.1016/j.pmedr.2023.102438....
Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial
Giorgi Rossi P, Ronco G, Mancuso P, Carozzi F, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H,...
Young immigrant women and cervical cancer screening: participation and lesions detected at the first screening round
Battagello J, Monetti D, Rizzato S, Rosano A, Stocco CF, Zamberlan S, Rugge M, Zorzi M. Epidemiol Prev 2022;46(3):47-54. Abstract OBJECTIVES: to...
Developing evidence-based Multisociety Italian Guidelines for cervical cancer prevention: rationale, methods, and development process.
Venturelli F, the Multisociety Italian Guidelines for cervical cancer prevention Working Group. Eur J Gynaecol Oncol. 2021 vol. 42(4), 634-642....
A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test
Del Mistro A, Battagello J, Weis L, Bressan V, Selle V, Ramigni M, Dal Zotto A, Maggiolo A, Gori S, Frayle H, Zappa M, Zorzi M, The Consensus Study...
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study
Gori S, Battagello J, Gustinucci D, Campari C, Zorzi M, Frayle H, Passamonti B, Sartori G, Bulletti S, Fodero C, Cesarini E, Faggiano R, Del Mistro...
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
Benevolo M, Mancuso P, Allia E, Gustinucci D, Bulletti S, Cesarini E, Carozzi FM, Confortini M, Bisanzi S, Rubino T, Rollo F, Marchi N, Farruggio A,...
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo...
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
Del Mistro A, Giorgi Rossi P, Frayle H, Pasquale L, Campari C, Ronco G, Zorzi M. BJOG. 2019 Oct;126(11):1365-1371. doi: 10.1111/1471-0528.15893....